Monocytes from HIV-infected individuals show impaired cholesterol efflux and increased foam cell formation after transendothelial migration

Anna Maisa, Anna C. Hearps, Thomas A Angelovich, Candida F. Pereira, Jingling Zhou, Margaret D Y Shi, Clovis S. Palmer, William Anthony Muller, Suzanne M. Crowe, Anthony Jaworowski

Research output: Contribution to journalArticleResearchpeer-review

25 Citations (Scopus)

Abstract

Design: HIV-infected (HIV) individuals have an increased risk of atherosclerosis and cardiovascular disease which is independent of antiretroviral therapy and traditional risk factors. Monocytes play a central role in the development of atherosclerosis, and HIV-related chronic inflammation and monocyte activation may contribute to increased atherosclerosis, but the mechanisms are unknown. Methods: Using an in-vitro model of atherosclerotic plaque formation, we measured the transendothelial migration of purified monocytes from age-matched HIV and uninfected donors and examined their differentiation into foam cells. Cholesterol efflux and the expression of cholesterol metabolism genes were also assessed. Results: Monocytes from HIV individuals showed increased foam cell formation compared with controls (18.9 vs. 0%, respectively, P0.004) and serum from virologically suppressed HIV individuals potentiated foam cell formation by monocytes from both uninfected and HIV donors. Plasma tumour necrosis factor (TNF) levels were increased in HIV vs. control donors (5.9 vs. 3.5 pg/ml, P0.02) and foam cell formation was inhibited by blocking antibodies to TNF receptors, suggesting a direct effect on monocyte differentiation to foam cells. Monocytes from virologically suppressed HIV donors showed impaired cholesterol efflux and decreased expression of key genes regulating cholesterol metabolism, including the cholesterol transporter ABCA1 (P0.02). Conclusion: Monocytes from HIV individuals show impaired cholesterol efflux and are primed for foam cell formation following transendothelial migration. Factors present in HIV serum, including elevated TNF levels, further enhance foam cell formation. The proatherogenic phenotype of monocytes persists in virologically suppressed HIVP individuals and may contribute mechanistically to increased atherosclerosis in thispopulation.

Original languageEnglish
Pages (from-to)1445-1457
Number of pages13
JournalAIDS
Volume29
Issue number12
DOIs
Publication statusPublished - 31 Jul 2015

Keywords

  • Atherosclerosis
  • Cholesterol efflux
  • Foam cells
  • HIV
  • Innate immune activation
  • Macrophage
  • Monocytes

Cite this

Maisa, Anna ; Hearps, Anna C. ; Angelovich, Thomas A ; Pereira, Candida F. ; Zhou, Jingling ; Shi, Margaret D Y ; Palmer, Clovis S. ; Muller, William Anthony ; Crowe, Suzanne M. ; Jaworowski, Anthony. / Monocytes from HIV-infected individuals show impaired cholesterol efflux and increased foam cell formation after transendothelial migration. In: AIDS. 2015 ; Vol. 29, No. 12. pp. 1445-1457.
@article{c9e8c96a03f84fdeafc26f9dc6659b28,
title = "Monocytes from HIV-infected individuals show impaired cholesterol efflux and increased foam cell formation after transendothelial migration",
abstract = "Design: HIV-infected (HIV) individuals have an increased risk of atherosclerosis and cardiovascular disease which is independent of antiretroviral therapy and traditional risk factors. Monocytes play a central role in the development of atherosclerosis, and HIV-related chronic inflammation and monocyte activation may contribute to increased atherosclerosis, but the mechanisms are unknown. Methods: Using an in-vitro model of atherosclerotic plaque formation, we measured the transendothelial migration of purified monocytes from age-matched HIV and uninfected donors and examined their differentiation into foam cells. Cholesterol efflux and the expression of cholesterol metabolism genes were also assessed. Results: Monocytes from HIV individuals showed increased foam cell formation compared with controls (18.9 vs. 0{\%}, respectively, P0.004) and serum from virologically suppressed HIV individuals potentiated foam cell formation by monocytes from both uninfected and HIV donors. Plasma tumour necrosis factor (TNF) levels were increased in HIV vs. control donors (5.9 vs. 3.5 pg/ml, P0.02) and foam cell formation was inhibited by blocking antibodies to TNF receptors, suggesting a direct effect on monocyte differentiation to foam cells. Monocytes from virologically suppressed HIV donors showed impaired cholesterol efflux and decreased expression of key genes regulating cholesterol metabolism, including the cholesterol transporter ABCA1 (P0.02). Conclusion: Monocytes from HIV individuals show impaired cholesterol efflux and are primed for foam cell formation following transendothelial migration. Factors present in HIV serum, including elevated TNF levels, further enhance foam cell formation. The proatherogenic phenotype of monocytes persists in virologically suppressed HIVP individuals and may contribute mechanistically to increased atherosclerosis in thispopulation.",
keywords = "Atherosclerosis, Cholesterol efflux, Foam cells, HIV, Innate immune activation, Macrophage, Monocytes",
author = "Anna Maisa and Hearps, {Anna C.} and Angelovich, {Thomas A} and Pereira, {Candida F.} and Jingling Zhou and Shi, {Margaret D Y} and Palmer, {Clovis S.} and Muller, {William Anthony} and Crowe, {Suzanne M.} and Anthony Jaworowski",
year = "2015",
month = "7",
day = "31",
doi = "10.1097/QAD.0000000000000739",
language = "English",
volume = "29",
pages = "1445--1457",
journal = "AIDS",
issn = "0269-9370",
publisher = "Lippincott Williams & Wilkins",
number = "12",

}

Monocytes from HIV-infected individuals show impaired cholesterol efflux and increased foam cell formation after transendothelial migration. / Maisa, Anna; Hearps, Anna C.; Angelovich, Thomas A; Pereira, Candida F.; Zhou, Jingling; Shi, Margaret D Y; Palmer, Clovis S.; Muller, William Anthony; Crowe, Suzanne M.; Jaworowski, Anthony.

In: AIDS, Vol. 29, No. 12, 31.07.2015, p. 1445-1457.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Monocytes from HIV-infected individuals show impaired cholesterol efflux and increased foam cell formation after transendothelial migration

AU - Maisa, Anna

AU - Hearps, Anna C.

AU - Angelovich, Thomas A

AU - Pereira, Candida F.

AU - Zhou, Jingling

AU - Shi, Margaret D Y

AU - Palmer, Clovis S.

AU - Muller, William Anthony

AU - Crowe, Suzanne M.

AU - Jaworowski, Anthony

PY - 2015/7/31

Y1 - 2015/7/31

N2 - Design: HIV-infected (HIV) individuals have an increased risk of atherosclerosis and cardiovascular disease which is independent of antiretroviral therapy and traditional risk factors. Monocytes play a central role in the development of atherosclerosis, and HIV-related chronic inflammation and monocyte activation may contribute to increased atherosclerosis, but the mechanisms are unknown. Methods: Using an in-vitro model of atherosclerotic plaque formation, we measured the transendothelial migration of purified monocytes from age-matched HIV and uninfected donors and examined their differentiation into foam cells. Cholesterol efflux and the expression of cholesterol metabolism genes were also assessed. Results: Monocytes from HIV individuals showed increased foam cell formation compared with controls (18.9 vs. 0%, respectively, P0.004) and serum from virologically suppressed HIV individuals potentiated foam cell formation by monocytes from both uninfected and HIV donors. Plasma tumour necrosis factor (TNF) levels were increased in HIV vs. control donors (5.9 vs. 3.5 pg/ml, P0.02) and foam cell formation was inhibited by blocking antibodies to TNF receptors, suggesting a direct effect on monocyte differentiation to foam cells. Monocytes from virologically suppressed HIV donors showed impaired cholesterol efflux and decreased expression of key genes regulating cholesterol metabolism, including the cholesterol transporter ABCA1 (P0.02). Conclusion: Monocytes from HIV individuals show impaired cholesterol efflux and are primed for foam cell formation following transendothelial migration. Factors present in HIV serum, including elevated TNF levels, further enhance foam cell formation. The proatherogenic phenotype of monocytes persists in virologically suppressed HIVP individuals and may contribute mechanistically to increased atherosclerosis in thispopulation.

AB - Design: HIV-infected (HIV) individuals have an increased risk of atherosclerosis and cardiovascular disease which is independent of antiretroviral therapy and traditional risk factors. Monocytes play a central role in the development of atherosclerosis, and HIV-related chronic inflammation and monocyte activation may contribute to increased atherosclerosis, but the mechanisms are unknown. Methods: Using an in-vitro model of atherosclerotic plaque formation, we measured the transendothelial migration of purified monocytes from age-matched HIV and uninfected donors and examined their differentiation into foam cells. Cholesterol efflux and the expression of cholesterol metabolism genes were also assessed. Results: Monocytes from HIV individuals showed increased foam cell formation compared with controls (18.9 vs. 0%, respectively, P0.004) and serum from virologically suppressed HIV individuals potentiated foam cell formation by monocytes from both uninfected and HIV donors. Plasma tumour necrosis factor (TNF) levels were increased in HIV vs. control donors (5.9 vs. 3.5 pg/ml, P0.02) and foam cell formation was inhibited by blocking antibodies to TNF receptors, suggesting a direct effect on monocyte differentiation to foam cells. Monocytes from virologically suppressed HIV donors showed impaired cholesterol efflux and decreased expression of key genes regulating cholesterol metabolism, including the cholesterol transporter ABCA1 (P0.02). Conclusion: Monocytes from HIV individuals show impaired cholesterol efflux and are primed for foam cell formation following transendothelial migration. Factors present in HIV serum, including elevated TNF levels, further enhance foam cell formation. The proatherogenic phenotype of monocytes persists in virologically suppressed HIVP individuals and may contribute mechanistically to increased atherosclerosis in thispopulation.

KW - Atherosclerosis

KW - Cholesterol efflux

KW - Foam cells

KW - HIV

KW - Innate immune activation

KW - Macrophage

KW - Monocytes

UR - http://www.scopus.com/inward/record.url?scp=84942583775&partnerID=8YFLogxK

U2 - 10.1097/QAD.0000000000000739

DO - 10.1097/QAD.0000000000000739

M3 - Article

C2 - 26244384

AN - SCOPUS:84942583775

VL - 29

SP - 1445

EP - 1457

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 12

ER -